Solasia Pharma K.K.

 Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan

NDA filed in Japan ahead of anywhere else in the world New anti-cancer drug with a novel mechanism of action…

Read More »